
David Fidei
Examiner (ID: 6483)
| Most Active Art Unit | 3728 |
| Art Unit(s) | 1775, 2404, 3788, 3208, 3728, 2401, 2899 |
| Total Applications | 3497 |
| Issued Applications | 2707 |
| Pending Applications | 110 |
| Abandoned Applications | 680 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19578746
[patent_doc_number] => 12144828
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-19
[patent_title] => Human Kynureninase enzymes and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/296687
[patent_app_country] => US
[patent_app_date] => 2023-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18672
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296687
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296687 | Human Kynureninase enzymes and uses thereof | Apr 5, 2023 | Issued |
Array
(
[id] => 18649843
[patent_doc_number] => 20230295668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => METHODS AND COMPOSITIONS FOR INTEGRATION OF A DNA CONSTRUCT
[patent_app_type] => utility
[patent_app_number] => 18/185601
[patent_app_country] => US
[patent_app_date] => 2023-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18185601
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/185601 | METHODS AND COMPOSITIONS FOR INTEGRATION OF A DNA CONSTRUCT | Mar 16, 2023 | Pending |
Array
(
[id] => 18709494
[patent_doc_number] => 20230332112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => Novel In Vitro and In Vivo Enrichment Strategy Targeting Lymphocytes Derived from Vector Transduced HSCS for Therapy of Disorders
[patent_app_type] => utility
[patent_app_number] => 18/179876
[patent_app_country] => US
[patent_app_date] => 2023-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18179876
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/179876 | Novel In Vitro and In Vivo Enrichment Strategy Targeting Lymphocytes Derived from Vector Transduced HSCS for Therapy of Disorders | Mar 6, 2023 | Abandoned |
Array
(
[id] => 18844886
[patent_doc_number] => 20230407290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => METHYLATION-MEDIATED ADAPTER REMOVAL ON NUCLEIC ACID SEQUENCES
[patent_app_type] => utility
[patent_app_number] => 18/179311
[patent_app_country] => US
[patent_app_date] => 2023-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18179311
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/179311 | METHYLATION-MEDIATED ADAPTER REMOVAL ON NUCLEIC ACID SEQUENCES | Mar 5, 2023 | Pending |
Array
(
[id] => 18808936
[patent_doc_number] => 20230383271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => ENGINEERED PROTEINS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/175893
[patent_app_country] => US
[patent_app_date] => 2023-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41273
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175893
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175893 | ENGINEERED PROTEINS AND METHODS OF USE THEREOF | Feb 27, 2023 | Pending |
Array
(
[id] => 19020481
[patent_doc_number] => 20240076652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => ADENOSINE NUCLEOBASE EDITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/174569
[patent_app_country] => US
[patent_app_date] => 2023-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18174569
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/174569 | Adenosine nucleobase editors and uses thereof | Feb 23, 2023 | Issued |
Array
(
[id] => 19034533
[patent_doc_number] => 20240084348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => NUCLEIC ACID MUTAGENESIS METHODS
[patent_app_type] => utility
[patent_app_number] => 18/110444
[patent_app_country] => US
[patent_app_date] => 2023-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18110444
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/110444 | NUCLEIC ACID MUTAGENESIS METHODS | Feb 15, 2023 | Pending |
Array
(
[id] => 20453037
[patent_doc_number] => 12516087
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Methods and compositions comprising therapeutic gamma peptide nucleic acid-based molecules
[patent_app_type] => utility
[patent_app_number] => 18/165809
[patent_app_country] => US
[patent_app_date] => 2023-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 37
[patent_no_of_words] => 13974
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18165809
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/165809 | Methods and compositions comprising therapeutic gamma peptide nucleic acid-based molecules | Feb 6, 2023 | Issued |
Array
(
[id] => 19840348
[patent_doc_number] => 12252720
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-18
[patent_title] => Alpha-amylase variants and polynucleotides encoding same
[patent_app_type] => utility
[patent_app_number] => 18/165023
[patent_app_country] => US
[patent_app_date] => 2023-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 36018
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18165023
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/165023 | Alpha-amylase variants and polynucleotides encoding same | Feb 5, 2023 | Issued |
Array
(
[id] => 18376266
[patent_doc_number] => 20230151349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => METHODS FOR RAPID SEPARATION AND PURIFICATION OF DNA TOPOLOGICAL FORMS
[patent_app_type] => utility
[patent_app_number] => 18/098615
[patent_app_country] => US
[patent_app_date] => 2023-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18098615
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/098615 | Methods for rapid separation and purification of DNA topological forms | Jan 17, 2023 | Issued |
Array
(
[id] => 18567434
[patent_doc_number] => 20230257767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => Promoter of Hspa5 Gene
[patent_app_type] => utility
[patent_app_number] => 18/153851
[patent_app_country] => US
[patent_app_date] => 2023-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153851
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153851 | Promoter of Hspa5 Gene | Jan 11, 2023 | Abandoned |
Array
(
[id] => 18284890
[patent_doc_number] => 20230100362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => Conjugate Vaccines Containing Hydrazine-PEG-Hydrazine Linkers
[patent_app_type] => utility
[patent_app_number] => 18/074660
[patent_app_country] => US
[patent_app_date] => 2022-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18074660
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/074660 | Conjugate Vaccines Containing Hydrazine-PEG-Hydrazine Linkers | Dec 4, 2022 | Abandoned |
Array
(
[id] => 19564966
[patent_doc_number] => 12139728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => 2-O-sulfation enzyme mutant and 3-O-sulfation enzyme mutant, and method for using same
[patent_app_type] => utility
[patent_app_number] => 18/056853
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18323
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 288
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056853
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/056853 | 2-O-sulfation enzyme mutant and 3-O-sulfation enzyme mutant, and method for using same | Nov 17, 2022 | Issued |
Array
(
[id] => 18452016
[patent_doc_number] => 20230193295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => INCORPORATION OF UNNATURAL AMINO ACIDS INTO PROTEINS USING BASE EDITING
[patent_app_type] => utility
[patent_app_number] => 18/055274
[patent_app_country] => US
[patent_app_date] => 2022-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18055274
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/055274 | Incorporation of unnatural amino acids into proteins using base editing | Nov 13, 2022 | Issued |
Array
(
[id] => 18210039
[patent_doc_number] => 20230056300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => PLANT-DERIVED PROTEIN PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/982673
[patent_app_country] => US
[patent_app_date] => 2022-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982673
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982673 | PLANT-DERIVED PROTEIN PURIFICATION | Nov 7, 2022 | Abandoned |
Array
(
[id] => 18347965
[patent_doc_number] => 20230136076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => METHODS OF DETERMINING GENE EDITING EFICIENCIES IN CELLS
[patent_app_type] => utility
[patent_app_number] => 18/049114
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18049114
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/049114 | METHODS OF DETERMINING GENE EDITING EFICIENCIES IN CELLS | Oct 23, 2022 | Pending |
Array
(
[id] => 18879474
[patent_doc_number] => 20240002843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 17/965366
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 160767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17965366
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/965366 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES | Oct 12, 2022 | Pending |
Array
(
[id] => 18733555
[patent_doc_number] => 11802278
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Codon optimized GLA genes and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/045650
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 33
[patent_no_of_words] => 25598
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045650
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/045650 | Codon optimized GLA genes and uses thereof | Oct 10, 2022 | Issued |
Array
(
[id] => 18294923
[patent_doc_number] => 20230104609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => DIAGNOSTIC SYSTEM AND METHODS OF USING AND MANUFACTURING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/958486
[patent_app_country] => US
[patent_app_date] => 2022-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17958486
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/958486 | DIAGNOSTIC SYSTEM AND METHODS OF USING AND MANUFACTURING THE SAME | Oct 2, 2022 | Pending |
Array
(
[id] => 18109804
[patent_doc_number] => 20230002684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => TREATMENT FOR UPGRADING HEAVY CRUDE OIL
[patent_app_type] => utility
[patent_app_number] => 17/942543
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17942543
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/942543 | TREATMENT FOR UPGRADING HEAVY CRUDE OIL | Sep 11, 2022 | Pending |